Silence Therapeutics Welcomes Deep Track Capital as New Shareholder
01 déc. 2021 07h00 HE
|
Silence Therapeutics plc
1 December 2021 LONDON, Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA)...